SOPHiA GENETICS SA (SOPH)

SOPHiA GENETICS Market Cap

SOPHiA GENETICS has a market cap or net worth of $323.89 million as of April 19, 2024. Its market cap has increased by 6.61% in one year.

• Market Cap: 323.89M
• Enterprise Value: 206.84M
• 1-Year Change: 6.61%
• Ranking: #3281
• Category: Small-Cap
• Stock Price: $4.96

Market Cap Chart

Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $323.89M, a decrease of -71.09%. That is a compound annual growth rate of -36.42%.

Market Cap History

Date	Market Cap	% Change
Apr 18, 2024	313.10M	-1.04%
Apr 17, 2024	316.40M	-2.59%
Apr 16, 2024	324.80M	2.46%
Apr 15, 2024	317.00M	-2.82%
Apr 12, 2024	326.20M	-
Apr 11, 2024	326.20M	-1.57%
Apr 10, 2024	331.40M	2.22%
Apr 9, 2024	324.20M	2.27%
Apr 8, 2024	317.00M	-3.38%
Apr 5, 2024	328.10M	2.66%
Apr 4, 2024	319.60M	-4.85%
Apr 3, 2024	335.90M	3.83%
Apr 2, 2024	323.50M	2.89%
Apr 1, 2024	314.40M	-2.24%
Mar 28, 2024	321.60M	-6.27%
Mar 27, 2024	343.10M	6.92%
Mar 26, 2024	320.90M	2.92%
Mar 25, 2024	311.80M	-0.42%
Mar 22, 2024	313.10M	-
Mar 21, 2024	313.10M	-2.82%
Mar 20, 2024	322.20M	5.78%
Mar 19, 2024	304.60M	7.86%
Mar 18, 2024	282.40M	-2.92%
Mar 15, 2024	290.90M	5.94%
Mar 14, 2024	274.60M	-7.07%

View and export this data all the way back to 2021. Sign Up Today.

Related Stocks

Company	Market Cap
Atai Life Sciences	328.73M
Precigen	326.08M
Lyra Therapeutics	322.91M
Renovaro Biosciences	318.94M
Fractyl Health	317.91M
Esperion Therapeutics	313.57M
ESSA Pharma	312.76M
Atea Pharmaceuticals	312.25M